DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Cerubidine (Daunorubicin) - Side Effect Reports to FDA

 
 



This is an index of side effect / adverse reaction reports (a.k.a. adverse event reports) related to Cerubidine (Daunorubicin) and submitted to the FDA during the sample period of about a year. The information is not vetted and should not be considered as verified clinical evidence.

Reports by Event Outcome

All Cases (56)
Death (10)
Life Threatening Events (22)
Disability (4)

Reports by Reaction Type

Septic Shock (11)Sepsis (10)Pyrexia (9)Acute Respiratory Distress Syndrome (9)Aplasia (8)Pleural Effusion (7)Febrile Bone Marrow Aplasia (7)Generalised Oedema (6)Bone Marrow Failure (6)Cytolytic Hepatitis (6)Renal Failure (6)Cholestasis (5)

Below are a few examples of reports where side effects / adverse reactions may be related to Cerubidine (Daunorubicin). For a complete list or a specific selection of reports, please use the links above.

Possible Cerubidine side effects in 44 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-08

Patient: 44 year old female

Reactions: Gastrointestinal Haemorrhage, Haemorrhage, Lung Disorder, Mesenteric Panniculitis, Sepsis, Febrile Bone Marrow Aplasia, Bone Marrow Failure, Infection

Drug(s) suspected as cause:
Cerubidine



Possible Cerubidine side effects in 44 year old female

Reported by a physician from France on 2012-07-27

Patient: 44 year old female

Reactions: Lung Disorder, Gastrointestinal Haemorrhage, Mesenteric Panniculitis, Sepsis, Febrile Bone Marrow Aplasia

Drug(s) suspected as cause:
Mylotarg
    Dosage: 10.4 mg, 1x/day
    Indication: Acute Leukaemia
    Start date: 2008-07-25
    End date: 2008-07-25

Cytarabine
    Dosage: 348 mg, 1x/day
    Indication: Acute Leukaemia
    Start date: 2008-07-22
    End date: 2008-07-28

Cerubidine
    Dosage: 104.4 mg, 1x/day
    Indication: Acute Leukaemia
    Start date: 2008-07-22
    End date: 2008-07-24



Possible Cerubidine side effects in 44 year old female

Reported by a physician from France on 2012-07-13

Patient: 44 year old female

Reactions: Gastrointestinal Haemorrhage, Lung Disorder, Mesenteric Panniculitis, Sepsis, Febrile Bone Marrow Aplasia

Drug(s) suspected as cause:
Cerubidine
    Dosage: 104.4 mg, 1x/day
    Indication: Acute Leukaemia
    Start date: 2008-07-22
    End date: 2008-07-24

Mylotarg
    Dosage: 10.4 mg, 1x/day
    Indication: Acute Leukaemia
    Start date: 2008-07-25
    End date: 2008-07-25

Cytarabine
    Dosage: 348 mg, 1x/day
    Indication: Acute Leukaemia
    Start date: 2008-07-22
    End date: 2008-07-28



Possible Cerubidine side effects in male

Reported by a physician from France on 2012-07-12

Patient: male, weighing 61.5 kg (135.3 pounds)

Reactions: Haemorrhagic Stroke, Thrombocytopenia

Adverse event resulted in: death

Drug(s) suspected as cause:
Cytarabine
    Dosage: 3650 mg, qd
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-22
    End date: 2012-06-11

Cerubidine
    Dosage: 110 mg, qd
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-22
    End date: 2012-06-09

Afinitor
    Dosage: 70 mg, unk
    Administration route: Oral
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-22
    End date: 2012-05-28

Other drugs received by patient: Ondansetron; Emend; Glucose



Possible Cerubidine side effects in male

Reported by a physician from France on 2012-07-02

Patient: male, weighing 61.5 kg (135.3 pounds)

Reactions: Haemorrhagic Stroke, Thrombocytopenia

Adverse event resulted in: death

Drug(s) suspected as cause:
Cerubidine
    Dosage: 110 mg, qd
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-22
    End date: 2012-06-09

Cytarabine
    Dosage: 3650 mg, qd
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-22
    End date: 2012-06-11

Afinitor
    Dosage: 70 mg, unk
    Administration route: Oral
    Start date: 2012-05-22
    End date: 2012-05-28

Other drugs received by patient: Ondansetron; Emend; Glucose



Possible Cerubidine side effects in 55 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-06-04

Patient: 55 year old male

Reactions: Hyperbilirubinaemia, Cholestasis

Drug(s) suspected as cause:
Neupogen
    Dosage: 450 /mm3, 1x/day (5 ug/kg/day)
    Indication: Acute Myelomonocytic Leukaemia
    Start date: 2012-02-23
    End date: 2012-03-01

Cytarabine
    Dosage: 1 g, 1x/day (500 mg/m2)
    Indication: Acute Myelomonocytic Leukaemia
    Start date: 2012-02-23
    End date: 2012-02-25

Cerubidine
    Dosage: 120 mg, 1x/day (60 mg/m2)
    Indication: Acute Myelomonocytic Leukaemia
    Start date: 2012-02-23
    End date: 2012-02-25

Primperan TAB
    Dosage: 2 to 5 vials
    Indication: Vomiting
    Start date: 2012-02-24

Other drugs received by patient: Folic Acid; Zofran; Lasix; Hydrea; Paracetamol



Possible Cerubidine side effects in 55 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-06-04

Patient: 55 year old male

Reactions: Transfusion-Related Acute Lung Injury, Interstitial Lung Disease, Pleural Effusion

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cytarabine
    Dosage: 500 mg/m2 (1 g), 1x/day
    Indication: Acute Myelomonocytic Leukaemia
    Start date: 2012-02-23
    End date: 2012-02-25

Neupogen
    Dosage: 5 ug/kg (450 ug), 1x/day
    Indication: Acute Myelomonocytic Leukaemia
    Start date: 2012-02-23
    End date: 2012-03-01

Perikabiven 1200
    Dosage: unk
    Indication: Parenteral Nutrition
    Start date: 2012-02-29
    End date: 2012-03-01

Cerubidine
    Dosage: 60 mg/m2 (120 mg), 1x/day
    Indication: Acute Myelomonocytic Leukaemia
    Start date: 2012-02-23
    End date: 2012-02-25

Other drugs received by patient: Lasix; Primperan TAB; Gaviscon; Zofran; Tiorfan; Tramadol; Paracetamol; Periferalgan; Ceftriaxone; Aciclovir; Hydrea; Folic Acid



Possible Cerubidine side effects in 21 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-05-30

Patient: 21 year old male, weighing 82.6 kg (181.7 pounds)

Reactions: Toxic Optic Neuropathy

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Dexamethasone
    Dosage: unk
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-10-20
    End date: 2011-11-27

Valacyclovir Hydrochloride
    Dosage: 1 g, 1x/day
    Administration route: Oral
    Start date: 2011-10-13
    End date: 2011-12-07

Cerubidine
    Dosage: 60 mg, cyclic
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-10-20
    End date: 2011-11-10

Vfend
    Dosage: unk
    Start date: 2011-10-17
    End date: 2011-12-07

Phenoxymethyl Penicillin
    Dosage: 3 millioniu, 1x/day
    Administration route: Oral
    Start date: 2011-11-18
    End date: 2011-12-07

Vincristine
    Dosage: 2 mg, cyclic
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-10-20
    End date: 2011-11-10

Nexium
    Dosage: unk
    Administration route: Oral
    Start date: 2011-10-17
    End date: 2011-11-11

Nexium
    Dosage: unk
    Administration route: Oral
    Start date: 2011-11-15
    End date: 2011-12-07

Kidrolase
    Dosage: unk, cyclic
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-10-24
    End date: 2011-11-16

Other drugs received by patient: Methotrexate; Cyclophosphamide; Cytarabine



Possible Cerubidine side effects in 13 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-05-29

Patient: 13 year old male

Reactions: Fungal Infection, Bacterial Infection, Aplasia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cerubidine
    Dosage: unk
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-09-16
    End date: 2011-09-30

Methotrexate
    Dosage: unk
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-09-09
    End date: 2011-10-03

Kidrolase
    Dosage: unk
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-09-20
    End date: 2011-10-03

Hydrocortisone ^upjohn^
    Dosage: unk
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-09-20
    End date: 2011-10-03

Cytarabine
    Dosage: unk
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-09-20
    End date: 2011-10-03

Vincristine
    Dosage: unk
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-09-16
    End date: 2011-09-30

Other drugs received by patient: Bactrim DS; Amikacin; Fasturtec; Prednisolone; Tazobactam



Possible Cerubidine side effects in male

Reported by a physician from France on 2012-05-25

Patient: male

Reactions: Toxic Optic Neuropathy

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Vincristine
    Dosage: 2mg cyclic
    Indication: T-Cell Type Acute Leukaemia
    Start date: 2011-10-20
    End date: 2011-11-10

Phenoxymethyl Penicillin
    Dosage: 3iu6 per day
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-11-18
    End date: 2011-12-07

Nexium
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-10-17
    End date: 2011-12-07

Vfend
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-10-17
    End date: 2011-12-07

Dexamethasone
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-10-20
    End date: 2011-10-27

Valacyclovir Hydrochloride
    Dosage: 1g per day
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-10-13
    End date: 2011-12-07

Kidrolase
    Dosage: 10iu3 cyclic
    Indication: T-Cell Type Acute Leukaemia
    Start date: 2011-10-24
    End date: 2011-11-16

Cerubidine
    Dosage: 60mg cyclic
    Indication: T-Cell Type Acute Leukaemia
    Start date: 2011-10-20
    End date: 2011-11-10

Other drugs received by patient: Methotrexate; Cyclophosphamide; Cytarabine



Possible Cerubidine side effects in 21 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-05-24

Patient: 21 year old male, weighing 82.6 kg (181.7 pounds)

Reactions: Toxic Optic Neuropathy

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Vfend
    Dosage: unk
    Start date: 2011-10-17
    End date: 2011-12-07

Nexium
    Dosage: unk
    Administration route: Oral
    Start date: 2011-11-15
    End date: 2011-12-07

Valacyclovir Hydrochloride
    Dosage: 1 g, 1x/day
    Administration route: Oral
    Start date: 2011-10-13
    End date: 2011-12-07

Dexamethasone
    Dosage: unk
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-10-20
    End date: 2011-11-27

Cerubidine
    Dosage: 60 mg, cyclic
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-10-20
    End date: 2011-11-10

Phenoxymethyl Penicillin
    Dosage: 3 millioniu, 1x/day
    Administration route: Oral
    Start date: 2011-11-18
    End date: 2011-12-07

Vincristine
    Dosage: 2 mg, cyclic
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-10-20
    End date: 2011-11-10

Nexium
    Dosage: unk
    Administration route: Oral
    Start date: 2011-10-17
    End date: 2011-11-11

Kidrolase
    Dosage: unk, cyclic
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-10-24
    End date: 2011-11-16

Other drugs received by patient: Cyclophosphamide; Cytarabine; Methotrexate



Possible Cerubidine side effects in male

Reported by a physician from France on 2012-05-23

Patient: male

Reactions: Toxic Optic Neuropathy

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Vincristine
    Dosage: 2 mg per course
    Start date: 2011-10-27

Cerubidine
    Dosage: 60 mg per course
    Start date: 2011-10-20

Kidrolase
    Start date: 2011-10-24

Vfend
    Start date: 2011-10-17
    End date: 2011-11-27

Valacyclovir Hydrochloride
    Administration route: Oral
    Start date: 2011-10-13
    End date: 2011-12-07

Vincristine
    Dosage: 2 mg per course
    Start date: 2011-11-10

Cerubidine
    Dosage: 60 mg per course
    Start date: 2011-11-10

Vfend
    Start date: 2011-11-28
    End date: 2011-12-05

Dexamethasone
    Dosage: daily
    Administration route: Oral
    Start date: 2011-10-20
    End date: 2011-11-27

Phenoxymethyl Penicillin
    Dosage: 3 000 000 iu
    Administration route: Oral
    Start date: 2011-11-18
    End date: 2011-12-07

Kidrolase
    Start date: 2011-10-27

Kidrolase
    Start date: 2011-11-16

Cerubidine
    Dosage: 60 mg per course
    Start date: 2011-11-03

Nexium
    Dosage: daily
    Administration route: Oral
    Start date: 2011-10-17
    End date: 2011-11-11

Vincristine
    Dosage: 2 mg per course
    Start date: 2011-11-03

Kidrolase
    Start date: 2011-11-10

Kidrolase
    Start date: 2011-11-13

Kidrolase
    Start date: 2011-11-06

Nexium
    Administration route: Oral
    Start date: 2011-11-15
    End date: 2011-12-07

Vfend
    Start date: 2011-12-06
    End date: 2011-12-07

Vincristine
    Dosage: 2 mg per course
    Start date: 2011-10-20

Kidrolase
    Start date: 2011-10-30

Kidrolase
    Start date: 2011-11-03

Cerubidine
    Dosage: 60 mg per course
    Start date: 2011-10-27



Possible Cerubidine side effects in 13 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-05-23

Patient: 13 year old male

Reactions: Klebsiella Infection, Abdominal Pain, Diarrhoea, Fungal Infection, Blood Culture Positive, Bacterial Infection, Aplasia, Candidiasis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Methotrexate
    Dosage: intradiscal (intraspinal)
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-09-09
    End date: 2011-10-03

Hydrocortisone
    Dosage: intradiscal (intraspinal)
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-09-20
    End date: 2011-10-03

Cerubidine
    Dosage: intravenous (not otherwise specified)
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-09-16
    End date: 2011-09-30

Vincristine Sulfate
    Dosage: in accordance with the cycle,intravenous (not otherwise specified)
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-09-16
    End date: 2011-09-30

Cytarabine
    Dosage: intradiscal (intraspinal)
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-09-20
    End date: 2011-10-03

(Kidrolase)
    Dosage: intravenous (not otherwise specified)
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-09-20
    End date: 2011-10-03

Other drugs received by patient: Bactrim; (Amiklin / 00391001 / ); Tazobactam; Solupred / 00016217 / ); Fasturtec



Possible Cerubidine side effects in 55 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-05-22

Patient: 55 year old male

Reactions: Abdominal Pain, Hyperbilirubinaemia, Cholestasis, Pyrexia, Aplasia, Lung Disorder, Diarrhoea, Pleural Effusion, Acute Respiratory Distress Syndrome

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Neupogen
    Dosage: 450 mug, unk
    Indication: Acute Myelomonocytic Leukaemia
    Start date: 2012-02-23
    End date: 2012-03-02

Primperan TAB
    Dosage: unk
    Indication: Vomiting
    Start date: 2012-02-24
    End date: 2012-03-01

Cytarabine
    Dosage: 1 g, qd
    Indication: Acute Myelomonocytic Leukaemia
    Start date: 2012-02-23
    End date: 2012-02-25

Cerubidine
    Dosage: 120 mg, unk
    Indication: Acute Myelomonocytic Leukaemia
    Start date: 2012-02-23
    End date: 2012-02-25

Other drugs received by patient: Gaviscon; Acetaminophen; Perikabiven; Ondansetron; Tramadol Hydrochloride; Hydrea; Kabiven; Vancomycin; Folic Acid; Lasix; Ceftriaxone Sodium; Acyclovir; Rovamycine / 00074401 /; Piperacilline Panpharma; Acetaminophen; Tiorfan



Possible Cerubidine side effects in 55 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-05-18

Patient: 55 year old male

Reactions: Abdominal Pain, Hyperbilirubinaemia, Cholestasis, Pyrexia, Aplasia, Lung Disorder, Diarrhoea, Pleural Effusion, Acute Respiratory Distress Syndrome

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cerubidine
    Dosage: 120 mg, unk
    Indication: Acute Myelomonocytic Leukaemia
    Start date: 2012-02-23
    End date: 2012-02-25

Primperan TAB
    Dosage: unk
    Indication: Vomiting
    Start date: 2012-02-24
    End date: 2012-03-01

Cytarabine
    Dosage: 1 g, qd
    Indication: Acute Myelomonocytic Leukaemia
    Start date: 2012-02-23
    End date: 2012-02-25

Neupogen
    Dosage: 450 mug, unk
    Indication: Acute Myelomonocytic Leukaemia
    Start date: 2012-02-23
    End date: 2012-03-02

Other drugs received by patient: Vancomycin; Acyclovir; Rovamycine / 00074401 /; Hydrea; Perikabiven; Ceftriaxone Sodium; Tiorfan; Kabiven; Folic Acid; Lasix; Ondansetron; Acetaminophen; Gaviscon; Acetaminophen; Piperacilline Panpharma; Tramadol Hydrochloride



Possible Cerubidine side effects in 68 year old male

Reported by a physician from Switzerland on 2012-04-24

Patient: 68 year old male

Reactions: Bronchopulmonary Aspergillosis, Blood Bilirubin Increased, Alanine Aminotransferase Increased, Cholestasis, Cardiac Disorder, Hepatic Steatosis, Multi-Organ Failure, Hepatic Encephalopathy, Lower Gastrointestinal Haemorrhage, Upper Gastrointestinal Haemorrhage, Renal Failure Acute

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Tazobactam
    Dosage: unk
    Indication: Aspergilloma
    Start date: 2005-02-12
    End date: 2005-03-04

Cerubidine
    Dosage: unknown
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2005-02-09
    End date: 2005-03-07

Methotrexate Sodium
    Dosage: unknown
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2005-02-09
    End date: 2005-03-07

Oncovin
    Dosage: unknown
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2005-02-09
    End date: 2005-03-07

Cyclophosphamide
    Dosage: unknown
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2005-02-09
    End date: 2005-03-07

Valtrex
    Dosage: unknown
    Indication: Aspergilloma
    Start date: 2005-02-20
    End date: 2005-03-08

Asparaginase
    Dosage: unknown
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2005-02-09
    End date: 2005-03-07

Fungizone
    Dosage: unknown
    Indication: Aspergilloma
    Start date: 2005-02-01
    End date: 2005-02-01

Vfend
    Dosage: unk
    Indication: Aspergilloma
    Start date: 2005-02-20
    End date: 2005-03-08

Other drugs received by patient: Bactrim; Prednisone; Navoban; Torsemide



Possible Cerubidine side effects in 36 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-04-10

Patient: 36 year old male

Reactions: Palmar-Plantar Erythrodysaesthesia Syndrome, Coma, Pyrexia, Hallucination, Dermatitis Exfoliative

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cytarabine
    Dosage: unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-01-28
    End date: 2012-02-04

Cytarabine
    Dosage: 40 mg, unk
    Start date: 2012-02-09
    End date: 2012-02-09

Cytarabine
    Dosage: 3220 mg, unk
    Start date: 2012-02-10
    End date: 2012-02-12

Cerubidine
    Dosage: unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-01-30
    End date: 2012-02-01

Cytarabine
    Dosage: 40 mg, unk
    Start date: 2012-02-07
    End date: 2012-02-07

Cerubidine
    Dosage: 58 mg, cyclic
    Start date: 2012-02-10
    End date: 2012-02-11

Other drugs received by patient: Vfend; Rocephin; Piperacillin and Tazobactam; Piperacillin and Tazobactam; Depo-Medrol; Methotrexate; Rocephin; Methotrexate; Fasturtec; Hydrea; Vancomycin; Rovamycine; Flagyl; Depo-Medrol; Ofloxacin; Vfend; Piperacillin and Tazobactam; Vancomycin



Possible Cerubidine side effects in 36 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-04-03

Patient: 36 year old male

Reactions: Palmar-Plantar Erythrodysaesthesia Syndrome, Coma, Pyrexia, Hallucination, Dermatitis Exfoliative

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cytarabine
    Dosage: 3220 mg, unk
    Start date: 2012-02-10
    End date: 2012-02-12

Cerubidine
    Dosage: unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-01-30
    End date: 2012-02-01

Cytarabine
    Dosage: 40 mg, unk
    Start date: 2012-02-09
    End date: 2012-02-09

Cerubidine
    Dosage: 58 mg, cyclic
    Start date: 2012-02-10
    End date: 2012-02-11

Cytarabine
    Dosage: unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-01-28
    End date: 2012-02-04

Cytarabine
    Dosage: 40 mg, unk
    Start date: 2012-02-07
    End date: 2012-02-07

Other drugs received by patient: Rocephin; Ofloxacin; Flagyl; Piperacillin and Tazobactam; Piperacillin and Tazobactam; Fasturtec; Piperacillin and Tazobactam; Depo-Medrol; Methotrexate; Vfend; Vancomycin; Rocephin; Vancomycin; Depo-Medrol; Hydrea; Rovamycine; Vfend; Methotrexate



Possible Cerubidine side effects in 16 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2012-03-23

Patient: 16 year old female

Reactions: Mucosal Inflammation, Dermatitis Bullous

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cytarabine
    Dosage: 30 mg, single
    Indication: T-Cell Type Acute Leukaemia
    Start date: 2012-01-21
    End date: 2012-01-21

Methotrexate
    Dosage: 8220 mg, single
    Start date: 2012-01-20
    End date: 2012-01-20

Methotrexate
    Dosage: 12 mg, single
    Indication: T-Cell Type Acute Leukaemia
    Start date: 2012-01-21
    End date: 2012-01-21

Cerubidine
    Dosage: 57 mg, 1x/day
    Indication: T-Cell Type Acute Leukaemia
    Start date: 2012-01-24
    End date: 2012-01-24

Hydrocortisone
    Dosage: 15 mg, single
    Start date: 2012-01-26
    End date: 2012-01-26

Mesna
    Dosage: 330 mg, 1x/day
    Indication: T-Cell Type Acute Leukaemia
    Start date: 2012-01-20
    End date: 2012-01-24

Cytarabine
    Dosage: 30 mg, single
    Start date: 2012-01-26
    End date: 2012-01-26

Hydrocortisone
    Dosage: 15 mg, single
    Indication: T-Cell Type Acute Leukaemia
    Start date: 2012-01-21
    End date: 2012-01-21

Methotrexate
    Dosage: 12 mg, 1x/day
    Start date: 2012-01-26
    End date: 2012-01-26

Ifosfamide
    Dosage: 656 mg, 1x/day
    Indication: T-Cell Type Acute Leukaemia
    Start date: 2012-01-20
    End date: 2012-01-24

Eldisine
    Dosage: 4 mg, single
    Start date: 2012-01-20
    End date: 2012-01-20

Other drugs received by patient: Furosemide; Calcium Levofolinate



Possible Cerubidine side effects in 38 year old male

Reported by a physician from France on 2012-03-15

Patient: 38 year old male

Reactions: Acute Respiratory Distress Syndrome, Bone Marrow Failure, Septic Shock

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cytarabine
    Dosage: 380 mg, 1x/day
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-04-05
    End date: 2011-04-11

Cerubidine
    Dosage: 114 mg, 1x/day
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-04-05
    End date: 2011-04-07



Possible Cerubidine side effects in 68 year old male

Reported by a physician from Switzerland on 2012-02-10

Patient: 68 year old male

Reactions: Bronchopulmonary Aspergillosis, Blood Bilirubin Increased, Alanine Aminotransferase Increased, Cholestasis, Cardiac Disorder, Hepatic Steatosis, Multi-Organ Failure, Hepatic Encephalopathy, Lower Gastrointestinal Haemorrhage, Upper Gastrointestinal Haemorrhage, Renal Failure Acute

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Valtrex
    Dosage: unknown
    Indication: Aspergilloma
    Start date: 2005-02-20
    End date: 2005-03-08

Oncovin
    Dosage: unknown
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2005-02-09
    End date: 2005-03-07

Cerubidine
    Dosage: unknown
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2005-02-09
    End date: 2005-03-07

Methotrexate Sodium
    Dosage: unknown
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2005-02-09
    End date: 2005-03-07

Asparaginase
    Dosage: unknown
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2005-02-09
    End date: 2005-03-07

Fungizone
    Dosage: unknown
    Indication: Aspergilloma
    Start date: 2005-02-01
    End date: 2005-02-01

Cyclophosphamide
    Dosage: unknown
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2005-02-09
    End date: 2005-03-07

Tazobactam
    Dosage: unk
    Indication: Aspergilloma
    Start date: 2005-02-12
    End date: 2005-03-04

Vfend
    Dosage: unk
    Indication: Aspergilloma
    Start date: 2005-02-20
    End date: 2005-03-08

Other drugs received by patient: Prednisone; Torsemide; Bactrim; Navoban



Possible Cerubidine side effects in 51 year old female

Reported by a physician from France on 2012-01-20

Patient: 51 year old female

Reactions: Bone Marrow Failure

Drug(s) suspected as cause:
Cytarabine
    Dosage: 320 mg, 1x/day
    Indication: Acute Leukaemia
    Start date: 2011-02-11
    End date: 2011-02-17

Cerubidine
    Dosage: 96 mg, 1x/day
    Indication: Acute Leukaemia
    Start date: 2011-02-11
    End date: 2011-02-13



Possible Cerubidine side effects in 5 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-01-16

Patient: 5 year old male, weighing 18.0 kg (39.6 pounds)

Reactions: Sepsis, Generalised Oedema

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Gleevec
    Administration route: Oral
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-13
    End date: 2011-10-21

Cyclophosphamide
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-06
    End date: 2011-10-01

Kidrolase
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-06
    End date: 2011-10-14

Methotrexate
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-03
    End date: 2011-10-14

Vincristine Sulfate
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-06
    End date: 2011-10-13

Cerubidine
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-06
    End date: 2011-10-13

Cytarabine
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-10
    End date: 2011-10-14



Possible Cerubidine side effects in male

Reported by a health professional (non-physician/pharmacist) from France on 2012-01-09

Patient: male, weighing 18.0 kg (39.6 pounds)

Reactions: Urine Output Decreased, Pyrexia, Aplasia, Stomatococcal Infection, Pericardial Effusion, Generalised Oedema, Ascites, Staphylococcal Infection, Spleen Disorder, Oral Disorder, Sepsis, Hypoxia, Acute Respiratory Distress Syndrome, Pleural Effusion, Candidiasis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Cytarabine
    Dosage: 25 mg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-10
    End date: 2011-10-14

Gleevec
    Dosage: 200 mg, qd
    Administration route: Oral
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-13
    End date: 2011-10-21

Cerubidine
    Dosage: 31 mg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-06
    End date: 2011-10-13

Methotrexate
    Dosage: 12 mg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-03
    End date: 2011-10-14

Vincristine
    Dosage: 1.2 mg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-06
    End date: 2011-10-13

Kidrolase
    Dosage: 4800 iu, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-06
    End date: 2011-10-14

Cyclophosphamide
    Dosage: 780 mg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-06



Possible Cerubidine side effects in male

Reported by a health professional (non-physician/pharmacist) from France on 2012-01-09

Patient: male, weighing 18.0 kg (39.6 pounds)

Reactions: Urine Output Decreased, Pyrexia, Stomatococcal Infection, Aplasia, Generalised Oedema, Ascites, Pericardial Effusion, Staphylococcal Infection, Oral Disorder, Sepsis, Hypoxia, Pleural Effusion, Acute Respiratory Distress Syndrome, Candidiasis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Gleevec
    Dosage: 200 mg, qd
    Administration route: Oral
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-13
    End date: 2011-10-21

Cyclophosphamide
    Dosage: 780 mg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-06

Cytarabine
    Dosage: 25 mg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-10
    End date: 2011-10-14

Methotrexate
    Dosage: 12 mg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-03
    End date: 2011-10-14

Vincristine
    Dosage: 1.2 mg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-06
    End date: 2011-10-13

Kidrolase
    Dosage: 4800 iu, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-06
    End date: 2011-10-14

Cerubidine
    Dosage: 31 mg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-06
    End date: 2011-10-13



Possible Cerubidine side effects in 5 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-01-05

Patient: 5 year old male, weighing 18.0 kg (39.6 pounds)

Reactions: Sepsis, Generalised Oedema

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Gleevec
    Administration route: Oral
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-13
    End date: 2011-10-21

Cerubidine
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-06
    End date: 2011-10-13

Methotrexate
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-03
    End date: 2011-10-14

Cytarabine
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-10
    End date: 2011-10-14

Kidrolase
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-06
    End date: 2011-10-14

Cyclophosphamide
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-06
    End date: 2011-10-01

Vincristine Sulfate
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-06
    End date: 2011-10-13



Possible Cerubidine side effects in male

Reported by a health professional (non-physician/pharmacist) from France on 2012-01-02

Patient: male, weighing 18.0 kg (39.6 pounds)

Reactions: Urine Output Decreased, Pyrexia, Stomatococcal Infection, Aplasia, Ascites, Pericardial Effusion, Generalised Oedema, Staphylococcal Infection, Oral Disorder, Sepsis, Hypoxia, Pleural Effusion, Acute Respiratory Distress Syndrome, Candidiasis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Kidrolase
    Dosage: 4800 iu, unk
    Start date: 2011-10-06
    End date: 2011-10-14

Cerubidine
    Dosage: 31 mg, unk
    Start date: 2011-10-06
    End date: 2011-10-13

Cytarabine
    Dosage: 25 mg, unk
    Start date: 2011-10-10
    End date: 2011-10-14

Cyclophosphamide
    Dosage: 780 mg, unk
    Start date: 2011-10-06

Vincristine Sulfate
    Dosage: 1.2 mg, unk
    Start date: 2011-10-06
    End date: 2011-10-13

Gleevec
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2011-10-13
    End date: 2011-10-21

Methotrexate
    Dosage: 12 mg, unk
    Start date: 2011-10-03
    End date: 2011-10-14



Possible Cerubidine side effects in male

Reported by a health professional (non-physician/pharmacist) from France on 2011-12-31

Patient: male, weighing 18.0 kg (39.6 pounds)

Reactions: Urine Output Decreased, Pyrexia, Stomatococcal Infection, Aplasia, Pericardial Effusion, Generalised Oedema, Ascites, Staphylococcal Infection, Oral Disorder, Sepsis, Pleural Effusion, Hypoxia, Acute Respiratory Distress Syndrome, Candidiasis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Vincristine Sulfate
    Dosage: 1.2 mg, unk
    Start date: 2011-10-06
    End date: 2011-10-13

Cytarabine
    Dosage: 25 mg, unk
    Start date: 2011-10-10
    End date: 2011-10-14

Cerubidine
    Dosage: 31 mg, unk
    Start date: 2011-10-06
    End date: 2011-10-13

Methotrexate
    Dosage: 12 mg, unk
    Start date: 2011-10-03
    End date: 2011-10-14

Gleevec
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2011-10-13
    End date: 2011-10-21

Cyclophosphamide
    Dosage: 780 mg, unk
    Start date: 2011-10-06

Kidrolase
    Dosage: 4800 iu, unk
    Start date: 2011-10-06
    End date: 2011-10-14



Possible Cerubidine side effects in 61 year old female

Reported by a physician from France on 2011-12-27

Patient: 61 year old female, weighing 62.0 kg (136.4 pounds)

Reactions: Autoimmune Thrombocytopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cytarabine
    Dosage: 340 mg/24h, unk
    Start date: 2008-01-28
    End date: 2008-02-03

Cordarone
    Dosage: 200 mg/24h, unk
    Administration route: Oral
    Start date: 2008-01-19
    End date: 2008-04-14

Cerubidine
    Dosage: 105 mg/24h, unk
    Start date: 2008-01-28
    End date: 2008-01-30

Gemtuzumab Ozogamicin
    Dosage: 5 mg/24h, unk
    Start date: 2008-01-28
    End date: 2008-02-03



Possible Cerubidine side effects in 61 year old female

Reported by a physician from France on 2011-12-21

Patient: 61 year old female, weighing 62.0 kg (136.4 pounds)

Reactions: Autoimmune Thrombocytopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cerubidine
    Dosage: 105 mg/24h, unk
    Start date: 2008-01-28
    End date: 2008-01-30

Gemtuzumab Ozogamicin
    Dosage: 5 mg/24h, unk
    Start date: 2008-01-28
    End date: 2008-02-03

Cytarabine
    Dosage: 340 mg/24h, unk
    Start date: 2008-01-28
    End date: 2008-02-03

Cordarone
    Dosage: 200 mg/24h, unk
    Administration route: Oral
    Start date: 2008-01-19
    End date: 2008-04-14

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017